Stay updated on Canakinumab with Docetaxel in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.

Latest updates to the Canakinumab with Docetaxel in NSCLC: Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.4.1 is now shown in the page footer, replacing the previous v3.4.0. This is a minor platform update and does not alter the study record content.SummaryDifference0.0%

- Check9 days agoChange DetectedThe history page now shows a glossary option, green highlights for additions and red highlights for deletions, and revision labels (e.g., Revision: v3.4.0) with corresponding removals (v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.3.4 was added, replacing v3.3.3. This appears to be a minor site update with no substantive changes to the trial information on the page.SummaryDifference0.0%

- Check45 days agoChange DetectedAdded Revision: v3.3.3 to the Record History. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check74 days agoChange DetectedThe Record History now shows a new revision entry Revision: v3.3.2 and the older Revision: v3.2.0 entry is removed. This update affects only the history metadata of the page, not the core trial information.SummaryDifference0.0%

- Check81 days agoChange DetectedDifference0.3%

Stay in the know with updates to Canakinumab with Docetaxel in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.